{"id":968365,"date":"2026-05-28T16:31:25","date_gmt":"2026-05-28T20:31:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/"},"modified":"2026-05-28T16:31:25","modified_gmt":"2026-05-28T20:31:25","slug":"lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/","title":{"rendered":"LB Pharmaceuticals to Participate in Upcoming June Investor Events"},"content":{"rendered":"
\n

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder, and other neuropsychiatric diseases, today announced that members of its executive team, will present and participate in the following upcoming investor conferences:<\/p>\n

\n Jefferies Global Healthcare Conference<\/strong>\n <\/p>\n

\n Date:<\/strong> Thursday, June 4, 2026<\/p>\n

\n Time:<\/strong> 2:35 p.m. ET<\/p>\n

\n H.C. Wainwright 7<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual Neuro Perspectives Hybrid Conference <\/strong>\n <\/p>\n

\n Date:<\/strong> Tuesday, June 16, 2026<\/p>\n

\n Time:<\/strong> Presentation available on the LB Pharmaceuticals website<\/p>\n

The webcasts for the presentation and fireside chat will be available on the \u201cInvestors\u201d page\u00a0section\u00a0under the \u201cEvents<\/a>\u201d section of the Company\u2019s website at https:\/\/ir.lbpharma.us\/<\/a>, where a replay of the webcasts will be archived.<\/p>\n

\n About LB Pharmaceuticals<\/strong>\n <\/p>\n

LB Pharmaceuticals is a late-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder and other neuropsychiatric diseases. The Company is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the Company believes has the opportunity to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102, if approved, has the potential to become a mainstay of psychiatric practice by offering a balanced clinical activity and tolerability profile that provides a potentially attractive alternative to branded and generic therapeutics for the treatment of a broad range of neuropsychiatric diseases.<\/p>\n

\n Media and Investor Contact<\/strong>:\u00a0
Ellen Rose
erose@lbpharma.us<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder, and other neuropsychiatric diseases, today announced that members of its executive team, will present and participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026 Time: 2:35 p.m. ET H.C. Wainwright 7 th Annual Neuro Perspectives Hybrid Conference Date: Tuesday, June 16, 2026 Time: Presentation available on the LB Pharmaceuticals website The webcasts for the presentation and fireside chat will be available on the \u201cInvestors\u201d page\u00a0section\u00a0under the \u201cEvents\u201d section of the Company\u2019s website at https:\/\/ir.lbpharma.us\/, where a replay of … <\/p>\n

Continue reading “LB Pharmaceuticals to Participate in Upcoming June Investor Events”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-968365","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLB Pharmaceuticals to Participate in Upcoming June Investor Events - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LB Pharmaceuticals to Participate in Upcoming June Investor Events - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder, and other neuropsychiatric diseases, today announced that members of its executive team, will present and participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026 Time: 2:35 p.m. ET H.C. Wainwright 7 th Annual Neuro Perspectives Hybrid Conference Date: Tuesday, June 16, 2026 Time: Presentation available on the LB Pharmaceuticals website The webcasts for the presentation and fireside chat will be available on the \u201cInvestors\u201d page\u00a0section\u00a0under the \u201cEvents\u201d section of the Company\u2019s website at https:\/\/ir.lbpharma.us\/, where a replay of … Continue reading "LB Pharmaceuticals to Participate in Upcoming June Investor Events"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-28T20:31:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"LB Pharmaceuticals to Participate in Upcoming June Investor Events\",\"datePublished\":\"2026-05-28T20:31:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/\",\"name\":\"LB Pharmaceuticals to Participate in Upcoming June Investor Events - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==\",\"datePublished\":\"2026-05-28T20:31:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LB Pharmaceuticals to Participate in Upcoming June Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LB Pharmaceuticals to Participate in Upcoming June Investor Events - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"LB Pharmaceuticals to Participate in Upcoming June Investor Events - Market Newsdesk","og_description":"NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) — LB Pharmaceuticals Inc (\u201cLB Pharmaceuticals\u201d or the \u201cCompany\u201d) (Nasdaq: LBRX), a late-stage biopharmaceutical company developing novel therapies for schizophrenia, bipolar depression, adjunctive treatment of major depressive disorder, and other neuropsychiatric diseases, today announced that members of its executive team, will present and participate in the following upcoming investor conferences: Jefferies Global Healthcare Conference Date: Thursday, June 4, 2026 Time: 2:35 p.m. ET H.C. Wainwright 7 th Annual Neuro Perspectives Hybrid Conference Date: Tuesday, June 16, 2026 Time: Presentation available on the LB Pharmaceuticals website The webcasts for the presentation and fireside chat will be available on the \u201cInvestors\u201d page\u00a0section\u00a0under the \u201cEvents\u201d section of the Company\u2019s website at https:\/\/ir.lbpharma.us\/, where a replay of … Continue reading \"LB Pharmaceuticals to Participate in Upcoming June Investor Events\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-28T20:31:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"LB Pharmaceuticals to Participate in Upcoming June Investor Events","datePublished":"2026-05-28T20:31:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/","name":"LB Pharmaceuticals to Participate in Upcoming June Investor Events - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==","datePublished":"2026-05-28T20:31:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyMjQzNiM3NjA5MjE0IzUwMDEzMDE5NQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lb-pharmaceuticals-to-participate-in-upcoming-june-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"LB Pharmaceuticals to Participate in Upcoming June Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968365","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=968365"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968365\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=968365"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=968365"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=968365"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}